Vaxart, a clinical-stage biotechnology company, appointed Edward Berg as the company’s first in-house general counsel.

Vaxart, a clinical-stage biotechnology company, appointed Edward Berg as the company’s first in-house general counsel.
We'll send a verification code to %EMAIL%.